The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1570
ISSUE1570
April 22, 2019
Eravacycline (Xerava) - An IV Tetracycline for Complicated Intra-Abdominal Infections
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Eravacycline (Xerava) - An IV Tetracycline for Complicated Intra-Abdominal Infections
April 22, 2019 (Issue: 1570)
Eravacycline (Xerava – Tetraphase), a new synthetic
tetracycline antibiotic, has been approved by the
FDA for IV treatment of complicated intra-abdominal
infections (cIAIs) in adults. Eravacycline is structurally
similar to tigecycline...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.